IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ziopharm Oncology Inc

CUSIP: 98973P10 | 2 institutional holders

Quarters

Q4 2015Q2 2015Q2 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2015

Arrowstreet Capital, Limited Partnership600,709
0.0% of portfolio›$5.0K
StyleTurnoverLocationFiled
Arrowstreet Capital, Limited Partnership
600,709$5.0K0.0%GARPHighBoston, MA2016-02-16